Ofatumumab sBLA Is Accepted for Treatment of Relapsing Multiple Sclerosis

The novel B-cell therapy has been assigned a PDUFA date of June 2020.

Source link

Related posts

CV Research Spin Abundant in the Era of Alternative Facts


Viktor Frankl on the Power of “Meaning” and the Conception of Psychiatry


Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World